Advertisement

Topics

Teva Announces Publication Of AIM-TD Study Results In /i> For The Investigational Use Of Deutetrabenazine In Tardive Dyskinesia

20:00 EDT 28 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Teva Announces Publication Of AIM-TD Study Results In /i> For The Investigational Use Of Deutetrabenazine In Tardive Dyskinesia

NEXT ARTICLE

More From BioPortfolio on "Teva Announces Publication Of AIM-TD Study Results In /i> For The Investigational Use Of Deutetrabenazine In Tardive Dyskinesia"

Advertisement
Quick Search
Advertisement
Advertisement